| __timestamp | Geron Corporation | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20707000 | 5280000 |
| Thursday, January 1, 2015 | 17831000 | 7148000 |
| Friday, January 1, 2016 | 18047000 | 19594000 |
| Sunday, January 1, 2017 | 11033000 | 22894000 |
| Monday, January 1, 2018 | 13432000 | 50337000 |
| Tuesday, January 1, 2019 | 52072000 | 109450000 |
| Wednesday, January 1, 2020 | 51488000 | 90450000 |
| Friday, January 1, 2021 | 85727000 | 104128000 |
| Saturday, January 1, 2022 | 95518000 | 108630000 |
| Sunday, January 1, 2023 | 125046000 | 134951000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Rhythm Pharmaceuticals, Inc. and Geron Corporation have demonstrated contrasting yet strategic approaches to R&D investment. From 2014 to 2023, Rhythm Pharmaceuticals increased its R&D spending by an impressive 2,456%, reflecting its aggressive pursuit of breakthrough therapies. In contrast, Geron Corporation's R&D expenses grew by 504%, indicating a more measured approach. Notably, in 2023, Rhythm Pharmaceuticals outspent Geron by approximately 8%, highlighting its intensified focus on research. This trend underscores the dynamic strategies employed by biotech firms to maintain a competitive edge and drive future growth. As the industry evolves, these investments will likely play a pivotal role in shaping the landscape of medical innovation.
Who Prioritizes Innovation? R&D Spending Compared for Bristol-Myers Squibb Company and Geron Corporation
Gilead Sciences, Inc. vs Geron Corporation: Strategic Focus on R&D Spending
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs Rhythm Pharmaceuticals, Inc.
Analyzing R&D Budgets: Incyte Corporation vs Rhythm Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Limited or Geron Corporation: Who Invests More in Innovation?
Research and Development Expenses Breakdown: BioMarin Pharmaceutical Inc. vs Rhythm Pharmaceuticals, Inc.
Pharming Group N.V. vs Geron Corporation: Strategic Focus on R&D Spending
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc.
R&D Insights: How ImmunityBio, Inc. and Geron Corporation Allocate Funds
Geron Corporation or MannKind Corporation: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Geron Corporation and Amphastar Pharmaceuticals, Inc.
R&D Insights: How Geron Corporation and Travere Therapeutics, Inc. Allocate Funds